Ukko Company
We are building a comprehensive, clinically validated map of the molecular structure of food allergies and disorders, unlocking critical knowledge about the biological mechanisms that drive human food interactions.
On the basis of this map, we design proteins that do not trigger an immune response. These proteins are then applied to the food and therapeutics markets.
Last Funding Date:
27.01.2021
Technology:
Others
Last Funding Type:
Series B
Investors Number:
8
Industry:
FoodScience
Founded Date:
01.01.2016
Employee Number:
1-10
Total Funding:
47699997
Headquarters:
Palo Alto, California, United States
Funding Status:
Early Stage Venture